1 (800) 463-1008 (Canada) or (908) 852-2311 (USA)


Using novel soluble cross-linked BioHyalux® , Biocia has a robust R&D program dedicated to the treatment of chronic glaucoma in patients who cannot tolerate medications or other surgical intervention. This research and development investment is dedicated to investigating cross-linked hyaluronan that exhibits unique physical and chemical properties as a long term viscosupplement following glaucoma viscosurgery.

The surgical objective is to create functional viscosupplemental implants during surgery to facilitate aqueous drainage over an extended period of time by preventing absolute wound closure due to natural healing.

Contact Biocia management for more information and co-development / licensing opportunities related to BioHyalux®.